0000950170-24-096986.txt : 20240814 0000950170-24-096986.hdr.sgml : 20240814 20240814160505 ACCESSION NUMBER: 0000950170-24-096986 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240325 FILED AS OF DATE: 20240814 DATE AS OF CHANGE: 20240814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TZIANABOS ARTHUR CENTRAL INDEX KEY: 0001586226 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38433 FILM NUMBER: 241207437 MAIL ADDRESS: STREET 1: C/O HOMOLOGY MEDICINES, INC. STREET 2: ONE PATRIOTS PARK CITY: BEDFORD STATE: MA ZIP: 01730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Q32 Bio Inc. CENTRAL INDEX KEY: 0001661998 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473468154 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-999-0232 MAIL ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Homology Medicines, Inc. DATE OF NAME CHANGE: 20151228 4 1 ownership.xml 4 X0508 4 2024-03-25 0001661998 Q32 Bio Inc. QTTB 0001586226 TZIANABOS ARTHUR Q32 BIO INC. 830 WINTER STREET WALTHAM MA 02451 true false false false false Common Stock 2024-03-25 4 M false 1095 A 8248 D Common Stock 2024-03-25 4 S false 265 24.20 D 7983 D Restricted Stock Units 2024-03-25 4 M false 1095 0.00 D Common Stock 1095 0 D Each restricted stock unit represents a contingent right to receive one share of Issuer Common Stock. The Issuer effected a 1-for-18 reverse stock split of its Common Stock on March 25, 2024. The amounts reported on this Form 4 have been adjusted to reflect the reverse stock split. Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. The restricted stock units vested in three equal installments, with the final installment vested on March 25, 2024. The restricted stock units had no expiration date. /s/ Eric Bell, Attorney-in-Fact 2024-08-14